$651.45M Market Cap.
LAB Market Cap. (MRY)
LAB Shares Outstanding (MRY)
LAB Assets (MRY)
Total Assets
$612.34M
Total Liabilities
$140.62M
Total Investments
$126.15M
LAB Income (MRY)
Revenue
$174.43M
Net Income
-$138.88M
Operating Expense
$259.50M
LAB Cash Flow (MRY)
CF Operations
-$143.45M
CF Investing
$363.17M
CF Financing
-$102.62M
LAB Dividends (MRY)
Period | Dividends | Yield % | Growth % | Payout Ratio | Coverage Ratio |
|---|---|---|---|---|---|
2024 | $0 | 0% | 0% | 0% | - |
2023 | $0 | 0% | 0% | 0% | - |
2022 | $0 | 0% | 0% | 0% | - |
2021 | $0 | 0% | 0% | 0% | - |
2020 | $0 | 0% | - | 0% | - |
LAB Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $612,344,000 (89.54%) | $323,067,000 (-17.23%) | $390,310,000 (41.82%) | $275,214,000 (-15.26%) |
Assets Current | $375,880,000 (137.58%) | $158,215,000 (-24.23%) | $208,815,000 (189.76%) | $72,066,000 (-38.75%) |
Assets Non-Current | $236,464,000 (43.44%) | $164,852,000 (-9.17%) | $181,495,000 (-10.66%) | $203,148,000 (-1.91%) |
Goodwill & Intangible Assets | $140,251,000 (30.20%) | $107,717,000 (-9.37%) | $118,851,000 (-11.51%) | $134,306,000 (-8.49%) |
Shareholders Equity | $471,722,000 (418.62%) | -$148,051,000 (-81.73%) | -$81,467,000 (-186.12%) | $94,596,000 (-31.97%) |
Property Plant & Equipment Net | $71,384,000 (30.14%) | $54,850,000 (-7.87%) | $59,535,000 (-8.62%) | $65,153,000 (17.09%) |
Cash & Equivalents | $166,728,000 (222.47%) | $51,704,000 (-36.41%) | $81,309,000 (185.79%) | $28,451,000 (-58.48%) |
Accumulated Other Comprehensive Income | $1,225,000 (155.16%) | -$2,221,000 (-17.14%) | -$1,896,000 (-109.04%) | -$907,000 (-909.82%) |
Deferred Revenue | $56,562,000 (91.77%) | $29,494,000 (-9.56%) | $32,611,000 (-17.57%) | $39,564,000 (-12.88%) |
Total Investments | $126,146,000 (99.63%) | $63,191,000 (-25.20%) | $84,475,000 (0%) | $0 (0%) |
Investments Current | $126,146,000 (99.63%) | $63,191,000 (-25.20%) | $84,475,000 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $59,265,000 (188.63%) | $20,533,000 (-4.38%) | $21,473,000 (3.11%) | $20,825,000 (5.77%) |
Trade & Non-Trade Receivables | $33,608,000 (70.95%) | $19,660,000 (13.77%) | $17,280,000 (-5.68%) | $18,320,000 (-27.94%) |
Trade & Non-Trade Payables | $12,282,000 (32.98%) | $9,236,000 (16.70%) | $7,914,000 (-25.35%) | $10,602,000 (14.99%) |
Accumulated Retained Earnings (Deficit) | -$1,185,651,000 (-18.48%) | -$1,000,752,000 (-8.06%) | -$926,096,000 (-25.83%) | -$735,998,000 (-8.75%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $1,081,000 (28.54%) | $841,000 (-20.28%) | $1,055,000 (-75.63%) | $4,329,000 (-50.22%) |
Total Debt | $32,996,000 (-66.40%) | $98,210,000 (-4.33%) | $102,655,000 (-8.05%) | $111,648,000 (17.06%) |
Debt Current | $6,228,000 (-90.25%) | $63,853,000 (1007.60%) | $5,765,000 (-41.71%) | $9,891,000 (232.69%) |
Debt Non-Current | $26,768,000 (-22.09%) | $34,357,000 (-64.54%) | $96,890,000 (-4.78%) | $101,757,000 (10.12%) |
Total Liabilities | $140,622,000 (-12.04%) | $159,865,000 (-0.41%) | $160,524,000 (-11.13%) | $180,618,000 (-2.74%) |
Liabilities Current | $65,894,000 (-39.73%) | $109,327,000 (151.66%) | $43,443,000 (-12.36%) | $49,568,000 (-8.63%) |
Liabilities Non-Current | $74,728,000 (47.86%) | $50,538,000 (-56.84%) | $117,081,000 (-10.66%) | $131,050,000 (-0.31%) |
LAB Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $174,432,000 (64.03%) | $106,340,000 (8.57%) | $97,948,000 (-24.99%) | $130,581,000 (-5.47%) |
Cost of Revenue | $90,170,000 (61.33%) | $55,890,000 (-8.22%) | $60,897,000 (-0.51%) | $61,208,000 (11.66%) |
Selling General & Administrative Expense | $156,608,000 (78.90%) | $87,541,000 (-23.72%) | $114,758,000 (16.05%) | $98,888,000 (1.01%) |
Research & Development Expense | $62,411,000 (140.52%) | $25,948,000 (-32.60%) | $38,498,000 (1.46%) | $37,944,000 (4.07%) |
Operating Expenses | $259,498,000 (104.25%) | $127,050,000 (-17.10%) | $153,256,000 (12.00%) | $136,832,000 (1.84%) |
Interest Expense | $3,316,000 (-27.39%) | $4,567,000 (5.45%) | $4,331,000 (13.29%) | $3,823,000 (7.03%) |
Income Tax Expense | $573,000 (26.77%) | $452,000 (115.97%) | -$2,830,000 (36.02%) | -$4,423,000 (-309.16%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$138,885,000 (-86.03%) | -$74,656,000 (60.73%) | -$190,098,000 (-220.91%) | -$59,237,000 (-11.73%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$138,885,000 (-86.03%) | -$74,656,000 (60.73%) | -$190,098,000 (-220.91%) | -$59,237,000 (-11.73%) |
Preferred Dividends Income Statement Impact | $46,014,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$184,899,000 (-147.67%) | -$74,656,000 (60.73%) | -$190,098,000 (-220.91%) | -$59,237,000 (-11.73%) |
Weighted Average Shares | $353,245,000 (346.24%) | $79,160,000 (1.09%) | $78,305,000 (3.32%) | $75,786,000 (5.19%) |
Weighted Average Shares Diluted | $353,245,000 (346.24%) | $79,160,000 (1.09%) | $78,305,000 (3.32%) | $75,786,000 (5.19%) |
Earning Before Interest & Taxes (EBIT) | -$134,996,000 (-93.86%) | -$69,637,000 (63.08%) | -$188,597,000 (-215.18%) | -$59,837,000 (-18.42%) |
Gross Profit | $84,262,000 (67.02%) | $50,450,000 (36.16%) | $37,051,000 (-46.59%) | $69,373,000 (-16.75%) |
Operating Income | -$175,236,000 (-128.77%) | -$76,600,000 (34.08%) | -$116,205,000 (-72.26%) | -$67,459,000 (-32.18%) |
LAB Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $363,174,000 (1694.60%) | $20,237,000 (122.96%) | -$88,127,000 (-637.71%) | -$11,946,000 (-129.88%) |
Net Cash Flow from Financing | -$102,616,000 (-1407.06%) | -$6,809,000 (-102.95%) | $230,758,000 (1345.94%) | $15,959,000 (-23.48%) |
Net Cash Flow from Operations | -$143,454,000 (-231.40%) | -$43,287,000 (51.56%) | -$89,370,000 (-102.83%) | -$44,061,000 (-185.79%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $116,319,000 (490.01%) | -$29,825,000 (-156.43%) | $52,857,000 (231.91%) | -$40,069,000 (-187.49%) |
Net Cash Flow - Business Acquisitions and Disposals | $278,648,000 (0%) | $0 (0%) | $0 (0%) | $1,318,000 (-91.70%) |
Net Cash Flow - Investment Acquisitions and Disposals | $92,881,000 (302.64%) | $23,068,000 (127.36%) | -$84,302,000 (0%) | $0 (0%) |
Capital Expenditure | -$8,355,000 (-195.13%) | -$2,831,000 (25.99%) | -$3,825,000 (71.16%) | -$13,264,000 (-4.30%) |
Issuance (Repayment) of Debt Securities | -$63,737,000 (-2959.87%) | -$2,083,000 (-111.47%) | $18,162,000 (11.17%) | $16,337,000 (0%) |
Issuance (Purchase) of Equity Shares | -$38,420,000 (-737.58%) | -$4,587,000 (-1395.76%) | $354,000 (-76.31%) | $1,494,000 (-93.21%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$785,000 (-2408.82%) | $34,000 (108.42%) | -$404,000 (-1823.81%) | -$21,000 (-105.45%) |
Share Based Compensation | $31,732,000 (141.80%) | $13,123,000 (-11.81%) | $14,880,000 (-7.58%) | $16,101,000 (11.42%) |
Depreciation Amortization & Accretion | $22,627,000 (468.52%) | $3,980,000 (13.75%) | $3,499,000 (-4.22%) | $3,653,000 (-39.43%) |
LAB Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 48.30% (1.90%) | 47.40% (25.40%) | 37.80% (-28.81%) | 53.10% (-11.94%) |
Profit Margin | -106.00% (-51.00%) | -70.20% (63.83%) | -194.10% (-327.53%) | -45.40% (-18.23%) |
EBITDA Margin | -64.40% (-4.38%) | -61.70% (67.35%) | -189.00% (-339.53%) | -43.00% (-33.54%) |
Return on Average Equity (ROAE) | -36.10% (-159.28%) | 60.90% (-87.22%) | 476.60% (957.19%) | -55.60% (-48.27%) |
Return on Average Assets (ROAA) | -26.60% (-23.72%) | -21.50% (57.09%) | -50.10% (-143.20%) | -20.60% (-18.39%) |
Return on Sales (ROS) | -77.40% (-18.17%) | -65.50% (65.97%) | -192.50% (-320.31%) | -45.80% (-25.14%) |
Return on Invested Capital (ROIC) | -45.50% (-15.19%) | -39.50% (45.21%) | -72.10% (-99.17%) | -36.20% (-9.04%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -3.37 (-43.13%) | -2.35 (-388.77%) | -0.48 (90.43%) | -5.03 (38.01%) |
Price to Sales Ratio (P/S) | 3.54 (115.44%) | 1.65 (75.94%) | 0.94 (-58.90%) | 2.27 (-27.29%) |
Price to Book Ratio (P/B) | 1.38 (216.54%) | -1.19 (-4.04%) | -1.14 (-135.93%) | 3.17 (-0.88%) |
Debt to Equity Ratio (D/E) | 0.3 (127.59%) | -1.08 (45.18%) | -1.97 (-203.20%) | 1.91 (42.89%) |
Earnings Per Share (EPS) | -0.52 (44.68%) | -0.94 (61.32%) | -2.43 (-211.54%) | -0.78 (-5.41%) |
Sales Per Share (SPS) | 0.49 (-63.22%) | 1.34 (7.35%) | 1.25 (-27.39%) | 1.72 (-10.12%) |
Free Cash Flow Per Share (FCFPS) | -0.43 (26.24%) | -0.58 (51.01%) | -1.19 (-57.41%) | -0.76 (-93.35%) |
Book Value Per Share (BVPS) | 1.33 (171.39%) | -1.87 (-79.81%) | -1.04 (-183.33%) | 1.25 (-35.34%) |
Tangible Assets Book Value Per Share (TABVPS) | 1.34 (-50.88%) | 2.72 (-21.55%) | 3.47 (86.50%) | 1.86 (-24.77%) |
Enterprise Value Over EBIT (EV/EBIT) | -4 (-33.33%) | -3 (-200.00%) | -1 (83.33%) | -6 (33.33%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -4.72 (-58.46%) | -2.98 (-306.28%) | -0.73 (89.04%) | -6.68 (36.41%) |
Asset Turnover | 0.25 (-17.97%) | 0.31 (18.60%) | 0.26 (-43.05%) | 0.45 (0.00%) |
Current Ratio | 5.7 (294.19%) | 1.45 (-69.90%) | 4.81 (230.61%) | 1.45 (-32.96%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$151,809,000 (-229.18%) | -$46,118,000 (50.51%) | -$93,195,000 (-62.57%) | -$57,325,000 (-103.76%) |
Enterprise Value (EV) | $530,279,896 (171.20%) | $195,528,027 (44.11%) | $135,678,838 (-63.88%) | $375,601,677 (-19.71%) |
Earnings Before Tax (EBT) | -$138,312,000 (-86.39%) | -$74,204,000 (61.54%) | -$192,928,000 (-203.06%) | -$63,660,000 (-17.67%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$112,369,000 (-71.15%) | -$65,657,000 (64.53%) | -$185,098,000 (-229.45%) | -$56,184,000 (-26.26%) |
Invested Capital | $272,467,000 (78.63%) | $152,529,000 (-38.83%) | $249,362,000 (42.87%) | $174,537,000 (15.90%) |
Working Capital | $309,986,000 (534.07%) | $48,888,000 (-70.44%) | $165,372,000 (635.05%) | $22,498,000 (-64.52%) |
Tangible Asset Value | $472,093,000 (119.22%) | $215,350,000 (-20.67%) | $271,459,000 (92.65%) | $140,908,000 (-20.83%) |
Market Capitalization | $651,452,896 (271.28%) | $175,463,027 (89.12%) | $92,776,838 (-69.06%) | $299,823,677 (-32.58%) |
Average Equity | $512,158,000 (517.82%) | -$122,577,750 (-207.30%) | -$39,888,750 (-137.43%) | $106,580,250 (-24.58%) |
Average Assets | $695,070,500 (100.04%) | $347,458,250 (-8.46%) | $379,571,250 (31.81%) | $287,978,750 (-5.60%) |
Invested Capital Average | $296,932,750 (68.58%) | $176,134,750 (-32.66%) | $261,569,500 (58.15%) | $165,388,500 (8.72%) |
Shares | 372,258,798 (368.87%) | 79,395,035 (0.12%) | 79,296,443 (3.67%) | 76,485,632 (3.19%) |
